SF
PBYI icon

Synovus Financial’s Puma Biotechnology PBYI Stock Holding History

Synovus Financial’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-23
Closed – – 1228
2020
Q2 		$0 Hold
23
– – ﹤0.01% 1971
2020
Q1 		$0 Hold
23
– – ﹤0.01% 2201
2019
Q4 		$0 Hold
23
– – ﹤0.01% 1580
2019
Q3 		$0 Hold
23
– – ﹤0.01% 1460
2019
Q2 		$0 Hold
23
– – ﹤0.01% 1421
2019
Q1 		$1K Hold
23
– – ﹤0.01% 1394
2018
Q4 		$0 Hold
23
– – ﹤0.01% 1429
2018
Q3 		$1K Buy
+23
New +$1.11K ﹤0.01% 1359

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Synovus Financial's PBYI Position: Q3 2020 in Review

Synovus Financial sold out of Puma Biotechnology (PBYI) in Q3 2020, closing a stake of 23 shares.

Synovus Financial first reported a position in PBYI in Q3 2018 and held it in 8 quarters. The position peaked at $1K in Q1 2019. 128 funds tracked by Wall St. Rank hold PBYI as of Q3 2020.

  • Synovus Financial reported no remaining Puma Biotechnology position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 23 Puma Biotechnology shares in Q3 2020.
  • Synovus Financial first reported a position in Puma Biotechnology in Q3 2018 and held it in 8 quarters.
  • Synovus Financial's Puma Biotechnology position peaked at $1K in Q1 2019.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.